Industries > Pharma > Pre-Filled Syringes Market Forecast 2016-2026

Pre-Filled Syringes Market Forecast 2016-2026

Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injector & Autoinjectors, and Glass Pre-Filled Syringes

PUBLISHED: 31 March 2016
PAGES: 206
PRODUCT CODE: PHA0103
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
SKU: PHA0103 Categories: ,

What can be expected from the pre-filled syringes market? Which areas are going to grow at the fastest rates? This Visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects there.
 
Our 206-page report provides 123 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall regional market and national level. You will see financial results, an interview, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2016-2026 and other analyses show you commercial prospects
Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and STEP analysis) and commercial developments.

Pre-Filled Syringes Market Forecast 2016-2026

See revenue forecasts for the leading submarkets and indications
How will submarkets perform to 2026? Our study forecasts revenues in the following national submarkets:
• National and Regional Markets
• Leading Therapeutic Sectors
• Leading Pre-Filled Device Therapies
• Pre-Filled Syringe and Related Technology Manufacturers

Leading companies and potential for market growth
Overall revenue for the Pre-filled syringe market will reach $6,940m in 2020, our work forecasts. We predict strong revenue growth through to 2026. A number of new injectable drugs and advances in technology are seen as factors driving growth over the forecast period.

Our work analyses the key companies in the market. See Visiongain’s analysis of 14 leading companies, including these:
• Becton, Dickinson and Company
• Gerresheimer
• Schott
• Baxter
• Nipro
• Weigao
• Unilife
• Roselabs
• SHL Group
• Ypsomed
• Haselmeier
• Owen Mumford
• Bespak
• Datwyler

Pre-Filled Syringes Market Forecast 2016-2026

A company profile gives you the following information where available:
• Discussion of a company’s activities and outlook
• Company news relevant to the market
• Historical revenues

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect the Pre-Filled Syringe industry?
Our new report discusses issues and events affecting the pre-filled syringe market. You will find discussions, including qualitative analyses on a range of topics.
You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Pre-Filled Syringes Market 2016-2026 report helps you
In summary, our 206-page report gives you the following knowledge:
• Revenue forecasts to 2026 for the Pre-Filled Syringes market – discover the industry’s prospects, finding promising places for investments and revenues
• Revenue forecasts to 2026 for the leading national markets – US, Japan, EU5, BRIC
• Revenue forecasts to 2026 for submarkets – discover prospects for leading therapeutic areas, as well as products within these areas. Identify the key trends driving and restraining growth in the market, including government policy and economic conditions relevant to the market.
• Assessment of 14 leading companies – historical revenue, news and upcoming product releases
• Discussion of what stimulates and restrains the market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain’s study is for everybody needing commercial analyses for the pre-filled syringes market and leading companies. You will find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Pre-Filled Syringes Market Forecast 2016-2026


Download sample pages

Complete the form below to download your free sample pages for Pre-Filled Syringes Market Forecast 2016-2026


Latest Pharma news

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

READ

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

READ

Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031

The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.

06 January 2021

READ

Categories

Category